3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethanol, 98%, 250mg

5-Hydroxypyrimidine-2-carbonitrile, 97%, 5g

BENZYL(3-BROMO-2-CHLOROPHENYL)SULFANE, 95.0%, 1g

tert-Butyl 4-oxoazepane-1-carboxylate, 98.0%, 100g

N-(2-(DIETHYLAMINO)ETHYL)-5-FLUOROPICOLINAMIDE, 95%, 250mg

2-Bromo-6-methoxybenzothiazole, 97.0%, 5g

5,10,15,20-Tetrakis(pentafluorophenyl)-21H,23H-porphine, 97%, 5g

(R)-4-Benzyl-3-(3-methylbutanoyl)oxazolidin-2-one, 95.0%, 1g

Ácido sulfámico, mínimo 99 %, cristal, 5 kg, envase de plástico.

5-Amino-3-thioxo-3H-(1,2)dithiole-4-carboxylic acid ethyl ester, 97%, 1g

2-(6,11-Dihydro-5H-benzo[c][1]benzazepin-6-ylmethyl)isoindole-1,3-dione, 97%, 250mg

2,5-Dichloronicotinamide, 97.0%, 25g

TRANS-METHYL 4-ACETYLCYCLOHEXANECARBOXYLATE, 95.0%, 250mg